November 17, 2015
Advaxis to get $1.6M through New Jersey Technology Business Tax (NOL) Program
Advaxis, a clinical-stage biotechnology company developing cancer immunotherapies, has received preliminary approval for a $1.8 million tax credit from the New Jersey Technology Business Tax Certificate Transfer (NOL) Program for the year 2015.